Neuronetics, Inc. (STIM)
NASDAQ: STIM · IEX Real-Time Price · USD
1.925
+0.025 (1.32%)
At close: Jul 19, 2024, 4:00 PM
1.940
+0.015 (0.78%)
Pre-market: Jul 22, 2024, 9:01 AM EDT
Neuronetics Employees
Neuronetics had 203 employees as of December 31, 2023. The number of employees increased by 9 or 4.64% compared to the previous year.
Employees
203
Change (1Y)
9
Growth (1Y)
4.64%
Revenue / Employee
$360,714
Profits / Employee
-$135,675
Market Cap
57.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Rockwell Medical | 237 |
Enzo Biochem | 190 |
Cytosorbents | 186 |
LENSAR | 130 |
Adlai Nortye | 127 |
Mural Oncology | 117 |
CollPlant Biotechnologies | 75 |
Rallybio | 43 |
STIM News
- 56 minutes ago - Aetna Policy Update Expands TMS Availability for Adolescents With Depression - GlobeNewsWire
- 11 days ago - California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults - GlobeNewsWire
- 12 days ago - BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents - GlobeNewsWire
- 21 days ago - NeuroStar® Launches Better Me Provider Program Nationwide - GlobeNewsWire
- 5 weeks ago - NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting - GlobeNewsWire
- 2 months ago - Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference - GlobeNewsWire
- 2 months ago - Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents - GlobeNewsWire
- 2 months ago - Neuronetics Reports Record First Quarter 2024 Financial and Operating Results - GlobeNewsWire